JP MORGAN/PUT/BOSTON SCIENTIFIC/60/0.1/16.08.24 Stock

Warrant

DE000JB88QP3

Delayed Börse Stuttgart 04:47:29 2024-07-03 EDT
0.024 EUR -14.29% Intraday chart for JP MORGAN/PUT/BOSTON SCIENTIFIC/60/0.1/16.08.24
Current month-7.69%
1 month-42.86%
Date Price Change
24-07-03 0.024 -14.29%
24-07-02 0.028 +21.74%
24-07-01 0.023 -11.54%
24-06-28 0.026 +8.33%
24-06-27 0.024 -20.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 04:47 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer J.P. Morgan
WKN JB88QP
ISINDE000JB88QP3
Date issued 2024-01-11
Strike 60 $
Maturity 2024-08-16 (43 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.023
Delta-0.07x
Omega 12.65
Premium21.44x
Gearing192.38x
Moneyness 0.7908
Difference Strike -16.11 $
Difference Strike %-26.85%
Spread 0.015
Spread %34.09%
Theoretical value 0.0365
Implied Volatility 48.74 %
Total Loss Probability 90.99 %
Intrinsic value 0.000000
Present value 0.0365
Break even 59.61 €
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.11 USD
Average target price
82.71 USD
Spread / Average Target
+8.68%
Consensus